PARADISE

Objective

The purpose of this study is to test if LCZ696 taken twice a day, compared to ramipril taken twice a day, is safe and effective in reducing complications following an acute myocardial infarction (post-AMI), such as death from cardiovascular (CV) causes, hospitalization for heart failure (HF), or outpatient HF.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI) or to review the Essentia Health FCOI policy, click here.

Last Updated: 06/23/2017

Research Study Categories

  • Adult Studies

Specialty

  • Cardiology
Contact
Clinical Trials at 866-839-4128
or clinicaltrials@eirh.org